Trials and PIs
View all posts »Symplicity HTN-2 with Dr Murray Esler
Nov 17, 2010 13:10 EST-
1Comments
-
Read later
Dr Murray Esler (IDI Heart and Diabetes Institute, Melbourne, Australia) discusses Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial of Endovascular Selective Renal Sympathetic Denervation for the Treatment of Hypertension with Dr Gabriel Steg.
Filmed during AHA 2010 in Chicago, IL on November 14.
See:
A revolutionary road for resistant hypertension? Renal denervation in Symplicity HTN-2
Your comments
 |
 |
 |
||
 |
|
 |
||
 |
 |
 |
||
 |
|
|
 |
|
 |
 |
 |
||
 |
|
|
 |
|
|
|
|
||
|
||||
You must be a member (with full membership) to post a comment.
Already a member?
Enjoy all the benefits of theheart.org
With full membership, you can check out our educational and editorial content, search the site, receive our newsletters, join discussions, download slides and much more.
Membership is free!
